Depression Screening and Treatment Recall in Male and Female Coronary Artery Disease Inpatients: Association with Symptoms One Year Later

dc.contributor.authorShanmugasegaram, Shamila
dc.contributor.authorGrace, Sherry
dc.date.accessioned2021-01-28T15:30:25Z
dc.date.available2021-01-28T15:30:25Z
dc.date.issued2017-03
dc.description.abstractBackground: Guidelines and statements recommend cardiac patients to be screened for depression. This study examined whether cardiac inpatients recall depression screening, how the recollection varies by gender, and how it is related to depressive symptoms and treatment one year later. Methods: 2635 cardiac inpatients from 11 hospitals across Ontario, Canada completed a survey and were mailed a follow-up survey one year later. The in-hospital survey queried patients about depression screening since their cardiac diagnosis, whether they had ever been diagnosed with depression, and if yes, what treatments they were recommended. Both surveys included the Beck Depression Inventory-II (BDI-II)to assess depressive symptoms. Results: Of the 1809 (68.7%) retained participants, 513 (30.0%) participants recalled depression screening and they were significantly more likely to be male. Screening recall was not significantly related to depressive symptoms at both time points(P>0.05). Participants who were recommended anti depressants had higher BDI-II scores than those who were not recommended antidepressants, both as inpatients (P<0.01) and one year later (P<0.05).There was no significant change in depressive symptoms over time in patients who received any type of therapy (P > 0.05).Conclusion: Less than one-third of cardiac inpatients recalled being screened for depression. Recall of screening was not significantly related to depressive symptoms, and use of treatment was related to greater symptoms. Improved patient-provider communication regarding depression screening in cardiac patients is warranted, as well as better monitoring of treatment response in clinical practice.en_US
dc.identifier.citationHeart & Lung Volume 46, Issue 3, May–June 2017, Pages 153-158en_US
dc.identifier.issn0147-9563
dc.identifier.urihttps://doi.org/10.1016/j.hrtlng.2017.02.002en_US
dc.identifier.urihttp://hdl.handle.net/10315/38071
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.rightsElsevier Journals © <2017>. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0en_US
dc.rightsAttribution-NoDerivatives 4.0 International*
dc.rights.articlehttps://www.sciencedirect.com/science/article/abs/pii/S0147956317300675en_US
dc.rights.journalhttps://www.sciencedirect.com/journal/heart-and-lungen_US
dc.rights.publisherhttps://www.sciencedirect.com/en_US
dc.rights.urihttp://creativecommons.org/licenses/by-nd/4.0/*
dc.subjectcoronary artery diseaseen_US
dc.subjectdepressionen_US
dc.subjectscreeningen_US
dc.subjecttreatmenten_US
dc.titleDepression Screening and Treatment Recall in Male and Female Coronary Artery Disease Inpatients: Association with Symptoms One Year Lateren_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
AAM.10.1016.j.hrtlng.2017.02.002.pdf
Size:
148.11 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.83 KB
Format:
Item-specific license agreed upon to submission
Description: